Worth Financial Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Worth Financial Advisory Group's LLY Position: Q1 2026 in Review
Worth Financial Advisory Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,369 shares — an estimated $1.47M sold.
Worth Financial Advisory Group first reported a position in LLY in Q3 2024 and held it in 6 quarters. The position peaked at $1.47M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Worth Financial Advisory Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Worth Financial Advisory Group sold 1,369 Eli Lilly shares in Q1 2026, an estimated $1.47M.
- Worth Financial Advisory Group first reported a position in Eli Lilly in Q3 2024 and held it in 6 quarters.
- Worth Financial Advisory Group's Eli Lilly position peaked at $1.47M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Worth Financial Advisory Group's 13F filing for Q1 2026, filed 4 May 2026.